Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seth M Steinberg

Showing results (91-100 of 481) with videos related to

Pageof 49
Sort By:
Annals of Surgical Oncology|February 22, 2012
Association of type O blood with pancreatic neuroendocrine tumors in Von Hippel-Lindau syndromeAllison B Weisbrod, David J Liewehr, Seth M Steinberg, et al.
Blood|May 23, 2015
EBV-positive large B-cell lymphomas in young patients: a nodal lymphoma with evidence for a tolerogenic immune environmentAlina Nicolae, Stefania Pittaluga, Shahed Abdullah, et al.
Surgery|November 15, 2016
SDHB mutation status and tumor size but not tumor grade are important predictors of clinical outcome in pheochromocytoma and abdominal paragangliomaYasmine Assadipour, Samira M Sadowski, Meghna Alimchandani, et al.
Annals of Surgical Oncology|December 4, 2008
Cytoreductive surgery and continuous hyperthermic peritoneal perfusion in patients with mesothelioma and peritoneal carcinomatosis: hemodynamic, metabolic, and anesthetic considerationsNing Miao, James F Pingpank, H Richard Alexander, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2015
Complete Remissions of Adult T-cell Leukemia with Anti-CD25 Recombinant Immunotoxin LMB-2 and Chemotherapy to Block ImmunogenicityRobert J Kreitman, Maryalice Stetler-Stevenson, Elaine S Jaffe, et al.
Cancer Immunology, Immunotherapy : CII|August 6, 2015
The impact of leukapheresis on immune-cell number and function in patients with advanced cancerJames L Gulley, Jennifer Marté, Christopher R Heery, et al.
JAMA Dermatology|September 11, 2014
Risk factors and characterization of vitiligo and alopecia areata in patients with chronic graft-vs-host diseaseRena C Zuo, Haley B Naik, Seth M Steinberg, et al.
Leukemia Research|November 2, 2015
Impact of telomere length on survival in classic and variant hairy cell leukemiaEvgeny Arons, Hong Zhou, Daniel C Edelman, et al.
Cancer|July 4, 2014
Phase 1 study of the antimesothelin immunotoxin SS1P in combination with pemetrexed and cisplatin for front-line therapy of pleural mesothelioma and correlation of tumor response with serum mesothelin, megakaryocyte potentiating factor, and cancer antigen 125Raffit Hassan, Elad Sharon, Anish Thomas, et al.
Statistics in Medicine|April 27, 2010
The statistics of phase 0 trialsLarry V Rubinstein, Seth M Steinberg, Shivaani Kummar, et al.
Pageof 49

Showing results (91-100 of 481) with videos related to

Sort By:
Pageof 49
Annals of Surgical Oncology|February 22, 2012
Association of type O blood with pancreatic neuroendocrine tumors in Von Hippel-Lindau syndromeAllison B Weisbrod, David J Liewehr, Seth M Steinberg, et al.
Blood|May 23, 2015
EBV-positive large B-cell lymphomas in young patients: a nodal lymphoma with evidence for a tolerogenic immune environmentAlina Nicolae, Stefania Pittaluga, Shahed Abdullah, et al.
Surgery|November 15, 2016
SDHB mutation status and tumor size but not tumor grade are important predictors of clinical outcome in pheochromocytoma and abdominal paragangliomaYasmine Assadipour, Samira M Sadowski, Meghna Alimchandani, et al.
Annals of Surgical Oncology|December 4, 2008
Cytoreductive surgery and continuous hyperthermic peritoneal perfusion in patients with mesothelioma and peritoneal carcinomatosis: hemodynamic, metabolic, and anesthetic considerationsNing Miao, James F Pingpank, H Richard Alexander, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2015
Complete Remissions of Adult T-cell Leukemia with Anti-CD25 Recombinant Immunotoxin LMB-2 and Chemotherapy to Block ImmunogenicityRobert J Kreitman, Maryalice Stetler-Stevenson, Elaine S Jaffe, et al.
Cancer Immunology, Immunotherapy : CII|August 6, 2015
The impact of leukapheresis on immune-cell number and function in patients with advanced cancerJames L Gulley, Jennifer Marté, Christopher R Heery, et al.
JAMA Dermatology|September 11, 2014
Risk factors and characterization of vitiligo and alopecia areata in patients with chronic graft-vs-host diseaseRena C Zuo, Haley B Naik, Seth M Steinberg, et al.
Leukemia Research|November 2, 2015
Impact of telomere length on survival in classic and variant hairy cell leukemiaEvgeny Arons, Hong Zhou, Daniel C Edelman, et al.
Cancer|July 4, 2014
Phase 1 study of the antimesothelin immunotoxin SS1P in combination with pemetrexed and cisplatin for front-line therapy of pleural mesothelioma and correlation of tumor response with serum mesothelin, megakaryocyte potentiating factor, and cancer antigen 125Raffit Hassan, Elad Sharon, Anish Thomas, et al.
Statistics in Medicine|April 27, 2010
The statistics of phase 0 trialsLarry V Rubinstein, Seth M Steinberg, Shivaani Kummar, et al.
Pageof 49